201 related articles for article (PubMed ID: 28752441)
1. Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease.
Teckman JH; Blomenkamp KS
Methods Mol Biol; 2017; 1639():1-8. PubMed ID: 28752441
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitation of Monomer and Polymer Alpha-1 Antitrypsin by Centrifugal Separation and Assay by Western Blot of Soluble and Insoluble Components.
Blomenkamp KS; Teckman JH
Methods Mol Biol; 2017; 1639():227-234. PubMed ID: 28752463
[TBL] [Abstract][Full Text] [Related]
3. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
Teckman JH
COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
[TBL] [Abstract][Full Text] [Related]
4. Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions.
Teckman JH; Mangalat N
Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):261-8. PubMed ID: 25066184
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model.
Lindblad D; Blomenkamp K; Teckman J
Hepatology; 2007 Oct; 46(4):1228-35. PubMed ID: 17886264
[TBL] [Abstract][Full Text] [Related]
6. Advances in alpha-1-antitrypsin deficiency liver disease.
Teckman JH; Jain A
Curr Gastroenterol Rep; 2014 Jan; 16(1):367. PubMed ID: 24338605
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1-Antitrypsin Deficiency Liver Disease.
Patel D; Teckman JH
Clin Liver Dis; 2018 Nov; 22(4):643-655. PubMed ID: 30266154
[TBL] [Abstract][Full Text] [Related]
8. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
Tang Y; Fickert P; Trauner M; Marcus N; Blomenkamp K; Teckman J
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G156-65. PubMed ID: 27102560
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model.
Kaushal S; Annamali M; Blomenkamp K; Rudnick D; Halloran D; Brunt EM; Teckman JH
Exp Biol Med (Maywood); 2010 Jun; 235(6):700-9. PubMed ID: 20511674
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.
Teckman JH; An JK; Blomenkamp K; Schmidt B; Perlmutter D
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G851-62. PubMed ID: 14684378
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1-antitrypsin deficiency: diagnosis, pathophysiology, and management.
Teckman JH; Lindblad D
Curr Gastroenterol Rep; 2006 Feb; 8(1):14-20. PubMed ID: 16510030
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 Antitrypsin Deficiency Liver Disease.
Suri A; Patel D; Teckman JH
Clin Liver Dis; 2022 Aug; 26(3):391-402. PubMed ID: 35868681
[TBL] [Abstract][Full Text] [Related]
14. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
Brunt EM; Blomenkamp K; Ahmed M; Ali F; Marcus N; Teckman J
J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):626-30. PubMed ID: 20890217
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-antitrypsin deficiency in childhood.
Teckman JH
Semin Liver Dis; 2007 Aug; 27(3):274-81. PubMed ID: 17682974
[TBL] [Abstract][Full Text] [Related]
16. Alpha-1-antitrypsin deficiency.
Perlmutter DH
Semin Liver Dis; 1998; 18(3):217-25. PubMed ID: 9773422
[TBL] [Abstract][Full Text] [Related]
17. Autophagy in liver diseases.
Rautou PE; Mansouri A; Lebrec D; Durand F; Valla D; Moreau R
J Hepatol; 2010 Dec; 53(6):1123-34. PubMed ID: 20810185
[TBL] [Abstract][Full Text] [Related]
18. Review: alpha 1-antitrypsin deficiency associated liver disease.
Qu D; Teckman JH; Perlmutter DH
J Gastroenterol Hepatol; 1997 May; 12(5):404-16. PubMed ID: 9195389
[TBL] [Abstract][Full Text] [Related]
19. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency.
Wu Y; Whitman I; Molmenti E; Moore K; Hippenmeyer P; Perlmutter DH
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9014-8. PubMed ID: 8090762
[TBL] [Abstract][Full Text] [Related]
20. FBG1 Is the Final Arbitrator of A1AT-Z Degradation.
Wen JH; Wen H; Gibson-Corley KN; Glenn KA
PLoS One; 2015; 10(8):e0135591. PubMed ID: 26295339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
